Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
129318-43-0
Purity
95%
Sodium alendronate is indicated for the treatment and prevention of osteoporosis in men and postmenopausal women, treatment of glucocorticoid-induced osteoporosis, and Paget's disease of bone. It is an inhibitor of farnesyl pyrophosphate synthase.
Properties
Name
Sodium alendronate
Smiles
[Na+].NCCCC(O)(P(=O)(O)O)P(=O)(O)[O-]
Targets
Please log in to see this information
SDS
Alendros | alendronate | alendronate monosodium | alendronate sodium | fosamax | monosodium alendronate | sodium alendronate
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$39
2 mg
$41
5 mg
$43
10 mg
$45
15 mg
$47
20 mg
$50
25 mg
$55
30 mg
$59
35 mg
$62
40 mg
$64
45 mg
$67
50 mg
$69
75 mg
$72
100 mg
$74
Quantity
1
Total amount
$ 43
Alendros | alendronate | alendronate monosodium | alendronate sodium | fosamax | monosodium alendronate | sodium alendronate
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.